You are currently viewing our desktop site, do you want to download our app instead?
Moneyweb Android App Moneyweb iOS App Moneyweb Mobile Web App

NEW SENS search and JSE share prices

More about the app

SA’s vaccine compensation fund could cost R250m in first year

Mkhize said the potential cost was based on an estimate of between 800 and 2 000 successful claims and included the administrative costs of the fund.
Image: Anthony Devlin/Bloomberg

The South African government’s compensation fund to cover potential injuries from Covid-19 vaccines could cost around R250 million  ($17.5 million) in the first year, the health minister said in response to questions in parliament.

The African country hardest-hit by the coronavirus pandemic in terms of infections and deaths told vaccine manufacturers Johnson & Johnson and Pfizer it would set up the fund during negotiations to buy shots.

Moneyweb Insider INSIDERGOLD

Subscribe for full access to all our share and unit trust data tools, our award-winning articles, and support quality journalism in the process.

Choose an option:

R63 per month
R630 per year SAVE R126

You will be redirected to a checkout page.
To view all features and options, click here.

A monthly subscription is charged pro rata, based on the day of purchase. This is non-refundable and includes a R5 once-off sign-up fee.
A yearly subscription is refundable within 14 days of purchase and includes a 365-day membership.

Click here for more information.

“A contingent liability of approximately R250 million for the first year would be provided for compensation of vaccine injury in a Covid-19 Vaccine NFC (no-fault compensation) Fund,” Health Minister Zweli Mkhize said in written replies to a lawmaker.

Mkhize said the potential cost was based on an estimate of between 800 and 2 000 successful claims and included the administrative costs of the fund. He said a committee of experts would develop a vaccine injury table to assess compensation applications.

The minister said last week that the government had agreed to fully indemnify J&J and Pfizer against third-party claims and that vaccine manufacturers had made “difficult and sometimes unreasonable” demands during negotiations including non-refundable downpayments.

A J&J spokeswoman said on Monday that the company was still in talks with the South African government and was committed to making its vaccine available at a not-for-profit price.

Pfizer did not immediately respond to a request for comment on Monday but told Reuters last week it sought indemnity and liability protections in all its agreements, consistent with local laws.

J&J and Pfizer will supply South Africa with a combined 61 million vaccine doses, helping to ramp up immunisations after a slow start.

To date, South Africa has vaccinated roughly 290 000 health workers with J&J’s one-dose vaccine in a research study, but last week it paused the study while regulators interrogate a possible link between J&J’s vaccine and rare cases of blood clots.

The government expects the first commercial batch of J&J doses later this month and doses of Pfizer’s two-shot vaccine next month.

Between the J&J and Pfizer deals, South Africa has secured enough vaccines for 46 million of its roughly 60 million people.

In the 2021 budget presented in February, the government said it could spend up to R19.3 billion over three fiscal years on its vaccination programme.

COMMENTS   1

You must be signed in to comment.

SIGN IN SIGN UP

First I need to say I am NOT an anti-vaccination campaigner..

But looking at the latest covid stats for RSA, is it possible that close to herd immunity has already been reached?

Considering the low level of lockdown and minimal adherence the new case rate is impressively low. Similar to Israel on per capita basis even with their far higher vaccination levels.

Couldn’t we just vaccinate the elderly and those with serious underlying health issues? The change from R19 billion could pay for a lot of free education with perhaps far more benefits to the country.

Unless the new case stats are misleading because I see the death rate is still high. Think we are now among the highest deaths per case in the world and getting higher….

End of comments.

LATEST CURRENCIES  

USD / ZAR
GBP / ZAR
EUR / ZAR
BTC / USD

Podcasts

INSIDER SUBSCRIPTIONS APP VIDEOS RADIO / LISTEN LIVE SHOP OFFERS WEBINARS NEWSLETTERS TRENDING PORTFOLIO TOOL CPD HUB

Follow us:

Search Articles: Advanced Search
Click a Company: